Molecular Mechanisms Regulating the Cell Cycle in Eukaryotic Cells

Abstract The cell cycle is a fundamental process that regulates cellular growth, replication, and division, ensuring that cells proliferate under controlled conditions. Dysregulation of the cell cycle can lead to various diseases, including cancer. This article reviews the molecular mechanisms that govern the eukaryotic cell cycle, focusing on key regulators such as cyclins, cyclin-dependent kinases (CDKs), checkpoints, tumor suppressors, and oncogenes. Cyclins and CDKs are pivotal in regulating transitions between the different phases of the cell cycle: G1, S, G2, and M. The cell cycle is regulated by various checkpoints that ensure the cell is ready to proceed to the next phase. These checkpoints include the G1/S checkpoint, the G2/M checkpoint, and the spindle assembly checkpoint. Tumor suppressors such as p53, retinoblastoma (Rb), and CDK inhibitors (CKIs) like p21 act as negative regulators of the cell cycle, whereas oncogenes such as MYC and RAS promote unchecked cell division. Furthermore, the article discusses how DNA damage can lead to cell cycle arrest or apoptosis via proteins like p53 and members of the Bcl-2 family. Understanding these molecular mechanisms provides insights into the development of cancer therapies targeting the cell cycle. The article also discusses potential therapeutic approaches to restore proper cell cycle control in cancer cells.

Authors

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2026-02-14
DOI
https://doi.org/10.5281/zenodo.18638803
Primary Topic
Cancer-related Molecular Pathways
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Molecular Mechanisms Regulating the Cell Cycle in Eukaryotic Cells

Muhammad Suliman
Zenodo (CERN European Organization for Nuclear Research)
Cancer-related Molecular Pathways
article

Molecular Mechanisms Regulating the Cell Cycle in Eukaryotic Cells

Muhammad Suliman
article en

Abstract

Abstract The cell cycle is a fundamental process that regulates cellular growth, replication, and division, ensuring that cells proliferate under controlled conditions. Dysregulation of the cell cycle can lead to various diseases, including cancer. This article reviews the molecular mechanisms that govern the eukaryotic cell cycle, focusing on key regulators such as cyclins, cyclin-dependent kinases (CDKs), checkpoints, tumor suppressors, and oncogenes. Cyclins and CDKs are pivotal in regulating transitions between the different phases of the cell cycle: G1, S, G2, and M. The cell cycle is regulated by various checkpoints that ensure the cell is ready to proceed to the next phase. These checkpoints include the G1/S checkpoint, the G2/M checkpoint, and the spindle assembly checkpoint. Tumor suppressors such as p53, retinoblastoma (Rb), and CDK inhibitors (CKIs) like p21 act as negative regulators of the cell cycle, whereas oncogenes such as MYC and RAS promote unchecked cell division. Furthermore, the article discusses how DNA damage can lead to cell cycle arrest or apoptosis via proteins like p53 and members of the Bcl-2 family. Understanding these molecular mechanisms provides insights into the development of cancer therapies targeting the cell cycle. The article also discusses potential therapeutic approaches to restore proper cell cycle control in cancer cells.

Zenodo (CERN European Organization for Nuclear Research)
Good health and well-being
Openalex Percentile: Top 55%
Cancer-related Molecular Pathways
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.